Recombinant CD4 (Clenoliximab Biosimilar) antibody
-
- Target
- CD4 (Clenoliximab Biosimilar)
- Antibody Type
- Recombinant Antibody
- Reactivity
- Human, Chimpanzee
-
Host
- Rabbit
-
Clonality
- Monoclonal
-
Conjugate
- Un-conjugated
-
Application
- Flow Cytometry (FACS), Immunohistochemistry (IHC), ELISA, Blocking Reagent (BR), Surface Plasmon Resonance (SPR)
- Specificity
- The antibody binds to human CD4 with a Kd of 1.0 nM and an ED50 of 0.2 μg/mL.
- Characteristics
-
OriginalSpeciesName: Human
OriginalFormat: IgG4 (primatized)
- Purification
- Purified antibody.
- Purity
- > 98 % as determined by SDS-PAGE
- Endotoxin Level
- Endotoxin is < 1.0 EU/mg as determined by the LAL method
- Immunogen
- Domain 1 of human CD4.
- Clone
- CE9-1
- Isotype
- IgG lambda
-
anti-CD4 (Clenoliximab Biosimilar) antibody
Reactivity: Human, Chimpanzee FACS, IHC, ELISA, BR, SPR Host: Human Monoclonal CE9-1 unconjugated Recombinant Antibody
-
- Application Notes
- The antibody binds specifically to CD4, a molecule which is part of the immunolgobulin super-family, expressed on the surface of helper T cells. The CD4 Molecule acts as a co-receptor in the activation of T cells, aiding the interaction between the TCR and MHC II of the antigen-presenting cell. The antibody is classified as 'primatized', as the variable regions of the light and heavy chains are obtained from primates, while the lamda light chain and ?4 heavy chain constant domains are human. The antibody was engineered from the primatized IgG1 monoclonal antibody Keliximab by substituting two key residues. The role of the antibody as an immunosuppressor has been tested in vivo, by intravenous administration in chimpanzees and human volunteers. The antibody reached Phase II clinical trials with Biogen-Idec.
- Comment
-
NOT FOR THERAPEUTIC USE - This is a research-grade biosimilar. This chimeric rabbit antibody was made using the variable domain sequences of the original Human IgG4 (primatized) format, for improved compatibility with existing reagents, assays and techniques.
- Restrictions
- For Research Use only
-
- Buffer
- PBS with 0.02 % Proclin 300.
- Preservative
- ProClin
- Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- 4 °C,-20 °C
- Storage Comment
- Store at 4°C for up to 3 months. For longer storage, aliquot and store at -20°C.
-
- Target
- CD4 (Clenoliximab Biosimilar)
- Synonyms
- CD4mut antibody, CD4 molecule antibody, CD4 antibody
- Target Type
- Biosimilar
- Background
- P55, T cell surface antign T4/Leu-3.
- UniProt
- P01730
-
